Based on recent data, Mangoceuticals, Inc. (MGRX) shows an Average True Range (ATR) of 0.09 and an Enterprise Value of 5.72M. Its average trading volume over the past 3 months is 6.46M, indicating liquidity. These fundamental metrics provide insight into MGRX's underlying financial health and market activity.
| ATR | 0.09 |
| Enterprise Value | 5.72M |
| Avg Vol (3 Months) | 6.46M |
| Avg Vol (10 Days) | 86.66M |
Mangoceuticals, Inc. (MGRX) technical indicators as of February 22, 2026: the SMA 20 is 31.7%, SMA 50 at -21.31%, and SMA 200 at -66.04%. The RSI 14 value is 53.22, suggesting its current momentum. These technical analysis signals help assess MGRX's price trends and potential future movements.
| SMA 20 | 31.7% |
| SMA 50 | -21.31% |
| SMA 200 | -66.04% |
| RSI 14 | 53.22 |
Mangoceuticals, Inc. (MGRX) stock performance overview as of February 22, 2026: The 52-week high is $5.33 (currently -91.38% below), and the 52-week low is $0.34 (currently 55.84% above). Over the past year, MGRX's performance is -77.18%, compared to the S&P 500's 7.96% change.
| 52-Week High | 5.33 |
| 52-Week High Chg | -91.38% |
| 52-Week Low | 0.3401 |
| 52-Week Low Chg | +55.84% |
| S&P 500 52-Week Chg | 7.96% |
According to market data, Mangoceuticals, Inc. (MGRX) stock's recent performance metrics show that over the last month, MGRX is -49.87%, with a Year-to-Date (YTD) performance of -17.35%. Over the past year, the stock has seen a -77.18% change. These figures summarize MGRX's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 0.689 | 0.689 | 1.31 | 2.75 | 5.33 | 1.03 |
| Low | 0.35 | 0.3401 | 0.3401 | 0.3401 | 0.3401 | 0.3401 |
| Performance | -22.09% | -49.87% | -74.41% | -64.44% | -77.18% | -17.35% |
According to current financial data, MGRX stock's P/E (TTM) ratio is -0.31, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for MGRX, including P/S (12.98), P/B (0.39), and P/FCF (-1.03), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | MGRX | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -0.31 | -1.23 | 14.43 | 32.59 |
| P/S (TTM) | 12.98 | 3.71 | 8.3 | 5.98 |
| P/B (TTM) | 0.39 | 0 | 3.97 | 5.16 |
| P/FCF (TTM) | -1.03 | -7.99 | 2.9 | 30.24 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep